Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |